Variants of Uncertain Significance and “Missing Pathogenicity”
Authors:
Open Access
- 4 February 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 9 (3) , e015588
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2017
- Health and population effects of rare gene knockouts in adult humans with related parentsScience, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Population-Based Variation in Cardiomyopathy GenesCirculation: Cardiovascular Genetics, 2012
- Evaluating Pathogenicity of Rare Variants From Dilated Cardiomyopathy in the Exome EraCirculation: Cardiovascular Genetics, 2012
- A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding GenesScience, 2012
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)EP Europace, 2011
- Proof of “disease causing” mutationHuman Mutation, 1998
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationCell, 1990